The market for Parkinson’s disease (PD) drugs across the seven major geographies (7MM; USA, France, Germany, Italy, UK and ...

Fondazione Telethon, an Italian biomedical charity focused on rare genetic diseases, has submitted a Marketing Authorization ...

California-based ImmunityBio has entered into a collaboration and supply agreement with Sino-American biotech BeiGene (to be ...

Russia plans to significantly expand the geography of the export of its drugs this year, paying attention both to emerging ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for ...

Swiss generic and biosimilars drugmaker Sandoz today revealed that Francisco Ballester, president Region International and a ...

UK contract research organization hVIVO (AIM: HVO) is gearing up to test an inhaled antiviral candidate, IN-002, for ...

At Sweden’s annual life science conference, stakeholders from healthcare, academia, and industry discussed implementing the ...

The European Federation of Industries and Associations (EFPIA) has welcomed the publication of the Competitiveness Compass ...

Faisal Sukhtian has been appointed as chairman of the board of directors at Outlook Therapeutics, effective immediately.

The US Food and Drug Administration (FDA) has approved Avtozma (CT-P47, tocilizumab-anoh) in both an intravenous (IV) and subcutaneous (SC) formulation as a biosimilar to Actemra, developed by South ...

Japan’s Eisai and US partner Biogen have announced today update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab (trade name Leqembi) as a treatment for early ...